Michael M. Wick
2012
In 2012, Michael M. Wick earned a total compensation of $400.7K as President, Chief Executive Officer and Chairman at MabVax Therapeutics Holdings, a 49% decrease compared to previous year.
Compensation breakdown
| Salary | $400,667 |
|---|---|
| Total | $400,667 |
Wick received $400.7K in salary, accounting for 100% of the total pay in 2012.
Rankings
In 2012, Michael M. Wick's compensation ranked 9,396th out of 11,487 executives tracked by ExecPay. In other words, Wick earned more than 18.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,396 out of 11,487 | 18th |
Division Manufacturing | 3,469 out of 4,253 | 18th |
Major group Chemicals And Allied Products | 958 out of 1,203 | 20th |
Industry group Drugs | 719 out of 925 | 22nd |
Industry Pharmaceutical Preparations | 553 out of 700 | 21st |
Source: SEC filing on April 5, 2013.
Wick's colleagues
We found four more compensation records of executives who worked with Michael M. Wick at MabVax Therapeutics Holdings in 2012.
2012
William Kaplan
MabVax Therapeutics Holdings
General Counsel
2012
Wendy Wee
MabVax Therapeutics Holdings
Vice President, Finance and Controller
2012
Steven Schow
MabVax Therapeutics Holdings
Vice President, Research
2012
Marc Steuer
MabVax Therapeutics Holdings